FDA approved Lenz Therapeutics’ VIZZ for the treatment of presbyopia

Published on July 31, 2025
Vizz (Lenz Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.
Continue reading on website
Other news

The Neural Network: Exploring The Role of Neuromodulation in Dry Eye Disease Management

July 31, 2025
In this podcast, Marjan Farid, MD; Beeran Meghpara, MD; and John Hovanesian, MD; review the role of neuromodulation in the pathogenesis of dry eye disease (DED). Additionally, the expert panel discusses a case study of a typical patient presenting with DED and reviews current and newly available treatment options.

Stanton Optical Launches Advanced Eye Health Services Across 35 U.S. Locations

August 1, 2025
DELRAY BEACH, Fla.—Stanton Optical, a leading retail brand under Now Optics, announced that it has expanded on-site clinical services to 35 locations nationwide in partnership with Physicians Eyecare Group, an independent network of eye doctors and professionals. This expansion brings new diagnostic tools and treatments for dry eye disease and retinal health, increasing access to advanced care for